European journal of pharmacology · 2008
MAGUK proteins: new targets for pharmacological intervention in the glutamatergic synapse.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gardoni Fabrizio
Аннотация
In the postsynaptic density of excitatory glutamatergic synapses, membrane associated guanylate kinase (MAGUK) proteins, such as Post-Synaptic Density 95 (PSD-95), organize ionotropic glutamate receptors and their associated signalling proteins regulating the strength of synaptic activity. Modifications of MAGUK proteins function in the glutamatergic synapse such as alterations of MAGUK proteins interaction with N-Methyl-D-Aspartate (NMDA) receptors regulatory subunits are common events in several neurodegenerative disorders. Thus, a better knowledge and understanding of MAGUK structure and function as well as of the molecular events regulating MAGUK-mediated interactions in the glutamatergic synapse could lead to the identification of new targets for pharmaceutical intervention for neurodegenerative diseases.
Предметные рубрики MeSH
Alzheimer DiseaseAnimalsAntiparkinson AgentsChronic DiseaseDisks Large Homolog 4 ProteinDyskinesia, Drug-InducedGlutamic AcidGuanylate KinasesHumansHuntington DiseaseIntracellular Signaling Peptides and ProteinsLevodopaMembrane ProteinsPainProtein SubunitsReceptors, N-Methyl-D-AspartateStrokeSynapses